首页> 外文期刊>Biologicals: Journal of the International Association of Biological Standardization >Drivers and barriers in the consistency approach for vaccine batch release testing: Report of an international workshop
【24h】

Drivers and barriers in the consistency approach for vaccine batch release testing: Report of an international workshop

机译:疫苗批量释放测试一致方法中的司机和障碍:国际研讨会的报告

获取原文
获取原文并翻译 | 示例
           

摘要

Safety and potency assessment for batch release testing of established vaccines still relies partly on animal tests. An important avenue to move to batch release without animal testing is the consistency approach. This approach is based on thorough characterization of the vaccine, and the principle that the quality of subsequent batches is the consequence of the application of consistent production of batches monitored by a GMP quality system. Efforts to implement the consistency approach are supported by several drivers from industry, government, and research, but there are also several barriers that must be overcome. A workshop entitled "Consistency Approach, Drivers and Barriers" was organized, which aimed to discuss and identify drivers and barriers for the implementation of the 3Rs in the consistency approach from three different perspectives/domains (industry, regulatory and science frameworks). The workshop contributed to a better understanding of these drivers and barriers and resulted in recommendations to improve the overall regulatory processes for the consistency approach. With this report, we summarise the outcome of this workshop and intend to offer a constructive contribution to the international discussion on regulatory acceptance of the consistency approach. (C) 2017 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.
机译:建立疫苗的批量释放试验的安全性和效力评估仍然依赖于动物试验。在没有动物测试的情况下移动到批量释放的重要途径是一致性方法。这种方法基于透视疫苗的彻底表征,以及后续批次质量的原则是应用GMP质量系统监测的一致生产一致的批次的结果。实施一致方法的努力得到了来自行业,政府和研究的几个司机,但也必须克服几个障碍。组织了一个题为“一致性方法,司机和障碍”的研讨会,旨在从三个不同的角度/域名(行业,监管和科学框架)中讨论和识别实施3R的司机和障碍。该研讨会有助于更好地了解这些司机和障碍,并导致建议改善一致性方法的整体监管程序。通过本报告,我们总结了本讲习班的结果,并打算为国际对“一致性方法的监管接受的讨论提供建设性贡献”。 (c)2017年生物标准化国际联盟。 elsevier有限公司出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号